A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for the treatment of newly diagnosed or Recurrent Breast Carcinoma in frail or elderly patients.

Trial Details

NCT ID
NCT06202118
Phase
NA
Sponsor
Alpha Tau Medical LTD.
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Diffusing Alpha Radiation Emitters Therapy (DaRT)
Locations (sample)
  • Jerusalem, Israel|31.76904,35.21633

Key Eligibility Criteria

  • Histologically confirmed invasive breast tumor with no involvement of skin within 12 months.
  • Tumor size ≤ 4 centimeters in the longest diameter.
  • Tumor is not deemed as resectable with radical surgery or the patient does not wish to go through surgery
  • De-novo or recurrent lesions.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →